Vascular closure system now approved for use in venous procedures

Cardiva Medical announced its vascular closure system received an expanded indication in patients undergoing interventional cardiac catheterization procedures and can now be used for femoral venous closures.

According to a press release from the company, the vascular closure system (Vascade) consists of a thrombogenic bioabsorbable collagen patch and proprietary collapsible disc technology.

The device had already been approved for arterial closures and can now be used in 5-7F venous femoral venous closures, according to the release.

In contrast to manual compression, the current standard of care for venous closure, the vascular closure system does not require prolonged heavy pressure and lengthy bed rest to ensure hemostasis, the company stated in the release.

“Vascade has performed exceptionally well for our current patients, and this new indication will empower many physicians to use Vascade for vein closure," Joseph De Gregorio, MD, chief of invasive cardiology at Englewood Hospital and Medical Center in New Jersey, said in the release. "Successful vessel closure, and enabling a patient to walk as soon as possible after their procedure, are critical factors for recovery from interventional procedures. The ease of use of the Vascade system and its compelling clinical data will make it an attractive new option for closure following vein procedures.”

Disclosures: De Gregorio reports no relevant financial disclosures.